INTERNATIONAL STEM CELL CORPORATION
ISCOCIK 0001355790
Revenue (TTM)
$9.26M
+0.2% YoY
Q1 May 2026
Net Income (TTM)
−$290K
−100.0% YoY
Q1 May 2026
EPS Diluted (TTM)
−$0.05
−66.7% YoY
Q1 May 2026
Gross Margin
57.7%
Q1 May 2026
Operating Margin
-1.6%
Q1 May 2026
Net Margin
-3.1%
Q1 May 2026
Free Cash Flow (TTM)
$320K
Q1 May 2026
Cash
$304K
Q1 May 2026
Total Debt
—
Q1 May 2026
Shares Outstanding
8M sh
Q1 May 2026